Stem Cells and Cloning: Advances and Applications 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.Prospect of Exosome in Ligament Healing: A Systematical Review
CONCLUSION: Exosomes may serve as a cell-free therapeutic substitute for modulating the remodelling process, particularly in ligament healing.PMID:38162837 | PMC:PMC10757805 | DOI:10.2147/SCCAA.S438023 (Source: Stem Cells and Cloning: Advances and Applications)
Source: Stem Cells and Cloning: Advances and Applications - January 1, 2024 Category: Stem Cells Authors: Andre Yanuar Hasrayati Agustina Nicolaas C Budhiparama Nur Atik Source Type: research
Efficacy of Adipocyte-Derived Stem Cells-Conditioned Media in Telogen Effluvium
CONCLUSION: ADSC-CM was successfully applied as a new treatment option for patients with telogen effluvium. These findings provide another therapeutic and research area for dermatologists to optimize the management of telogen effluvium and reduce its impact on patients.PMID:38020326 | PMC:PMC10675655 | DOI:10.2147/SCCAA.S432179 (Source: Stem Cells and Cloning: Advances and Applications)
Source: Stem Cells and Cloning: Advances and Applications - November 29, 2023 Category: Stem Cells Authors: Shadi Zari Source Type: research
Erratum: A Response to Article "Do Mesenchymal Stem Cells Influence Keloid Recurrence?" [Response to Letter] [Corrigendum]
Stem Cells Cloning. 2023 Nov 11;16:75-76. doi: 10.2147/SCCAA.S447846. eCollection 2023.ABSTRACT[This corrects the article DOI: 10.2147/SCCAA.S405738.].PMID:38020327 | PMC:PMC10648947 | DOI:10.2147/SCCAA.S447846 (Source: Stem Cells and Cloning: Advances and Applications)
Source: Stem Cells and Cloning: Advances and Applications - November 29, 2023 Category: Stem Cells Source Type: research
Efficacy of Adipocyte-Derived Stem Cells-Conditioned Media in Telogen Effluvium
CONCLUSION: ADSC-CM was successfully applied as a new treatment option for patients with telogen effluvium. These findings provide another therapeutic and research area for dermatologists to optimize the management of telogen effluvium and reduce its impact on patients.PMID:38020326 | PMC:PMC10675655 | DOI:10.2147/SCCAA.S432179 (Source: Stem Cells and Cloning: Advances and Applications)
Source: Stem Cells and Cloning: Advances and Applications - November 29, 2023 Category: Stem Cells Authors: Shadi Zari Source Type: research
